3.19% -0.0081

IGC Pharma Inc (IGC)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der IGC Pharma Inc-Aktie (IGC)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	41.77% 0.191	0.328	0.33	0.257	0.412
Cost Of Revenue	47.13% 0.092	0.174	0.176	0.153	0.214
Gross Profit	35.71% 0.099	0.154	0.154	0.104	0.198
Operating Expenses	45.60% 2.998	2.059	-	-	1.958
Benefits Costs and Expenses	4.41% 2.012	1.927	-	-	2.129
Costs And Expenses	4.41% 2.012	1.927	-	-	2.129
Operating Income/Loss	52.18% -2.899	-1.905	-1.412	-1.878	-1.76
Income/Loss From Continuing Operations Before Tax	13.88% -1.821	-1.599	-1.197	-1.829	-1.717
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	13.88% -1.821	-1.599	-	-	-1.717
Net Income/Loss	13.88% -1.821	-1.599	-1.197	-1.829	-1.717
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	8.95% 90.46	83.03	-	77.63	76.01
Diluted Average Shares	8.95% 90.46	83.03	-	77.63	76.01
Basic Earnings Per Share	0.00% -0.02	-0.02	-	-0.02	-0.02
Diluted Earnings Per Share	0.00% -0.02	-0.02	-	-0.02	-0.02
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

OLMA

$6.58

4.22%

ZVRA

$9.94

3.21%

SLDB

$5.53

3.66%

AVTX

$11.27

6.16%

NVCT

$18.60

1.74%

WVE

$3.13

1.88%